dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ruiz de Porras, Vicenç |
dc.contributor.author | Bystrup, Sara |
dc.contributor.author | Cabrero-de Las Heras, Sara |
dc.contributor.author | Musulén, Eva |
dc.contributor.author | Palomero, Luis |
dc.contributor.author | Henar Alonso, Maria |
dc.contributor.author | Arango Corro, Diego |
dc.contributor.author | Nieto Raya, Rocio |
dc.date.accessioned | 2020-09-02T08:04:20Z |
dc.date.available | 2020-09-02T08:04:20Z |
dc.date.issued | 2019-10-11 |
dc.identifier.citation | Ruiz de Porras V, Bystrup B, Cabrero-de las Heras S, Musulén E, Palomero L, Alonso, et al. Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients. Cancers (Basel). 2019 Oct 11;11(10):1540. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/5204 |
dc.description | Cáncer colorrectal; Quinasa dependiente de ciclina 5 (Cdk5); Biomarcador pronóstico y predictivo |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;11(10) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Recte - Càncer |
dc.subject | Quinases dependents de ciclina |
dc.subject | Marcadors tumorals |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | Cyclin-Dependent Kinase 5 |
dc.subject.mesh | Biomarkers, Tumor |
dc.title | Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers11101540 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | cinasa 5 dependiente de la ciclina |
dc.subject.decs | marcadores tumorales |
dc.relation.publishversion | https://www.mdpi.com/2072-6694/11/10/1540 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Ruiz de Porras V, Bystrup S, Cabrero-de Las Heras S] Program of predictive and personalized cancer medicine (PMPPC), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Badalona, Spain. [Musulén E] Department of Pathology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Department of Pathology, Hospital Universitari General de Catalunya, Grupo Quirónsalud, Sant Cugat del Valles, Spain. [Palomero L] Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, L’Hospitalet del Llobregat, Spain. ONCOBELL Program, Bellvitge Institute for Biomedical Research, L’Hospitalet del Llobregat, Spain. [Henar Alonso M] ONCOBELL Program, Bellvitge Institute for Biomedical Research, L’Hospitalet del Llobregat, Spain. Oncology Data Analytics Program, Institut Català d’Oncologia (ICO), Barcelona, Sapin. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain. Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. [Nieto R, Arango D] Grup de Recerca en Investigació Biomèdica en Tumors de l'Aparell Digestiu, CIBBIM-Nanomedicine, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain |
dc.identifier.pmid | 31614664 |
dc.identifier.wos | 000498826000137 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/6PN/PI12%2F02228 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/6PN/PI09%2F01334 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00540 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PIE16%2F00011 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |